Immatics Stock Valuation

IMTX -  USA Stock  

USD 9.80  0.17  1.71%

Do you wonder what the value of Immatics NV is? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Immatics, is its stock price multiplied by the total number of shares outstanding, calculating Immatics' enterprise value requires a different approach. It uses Immatics' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Free Cash Flow is likely to drop to about (86 M) in 2022. Enterprise Value is likely to drop to about (70.4 M) in 2022.
Immatics NV retains a regular Real Value of $13.34 per share. The prevalent price of the firm is $9.8. At this time, the firm appears to be undervalued. Our model calculates the value of Immatics NV from evaluating the firm fundamentals such as Return On Asset of (23.41) %, shares outstanding of 62.91 M, and Return On Equity of (143.21) % as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage acquiring undervalued assets and dropping overvalued assets since, at some point, asset prices and their ongoing real values will come together.

Immatics Valuation 

 
Refresh
Immatics Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Immatics's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Undervalued
Today 9.80
Share
Please note that Immatics' price fluctuation is somewhat reliable at this time. Calculation of the real value of Immatics NV is based on 3 months time horizon. Increasing Immatics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Immatics NV is useful when determining the fair value of the Immatics stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Immatics. Since Immatics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Immatics Stock. However, Immatics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
13.34
Real Value
16.76
Upside
Estimating the potential upside or downside of Immatics NV helps investors to forecast how Immatics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Immatics more accurately as focusing exclusively on Immatics' fundamentals will not take into account other important factors:
Earnings
Estimates (3)
LowProjected EPSHigh
-1.65-0.850.65
Details
Hype
Prediction
LowEstimated ValueHigh
6.079.4912.91
Details
4 Analysts
Consensus
LowTarget PriceHigh
19.0025.2532.00
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Immatics' intrinsic value based on its ongoing forecasts of Immatics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Immatics' closest peers. When choosing an evaluation method for Immatics NV, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Immatics Investments

26.51 MillionShare

Immatics Valuation Drivers Correlation

Many accounts on the financial statements of Immatics NV are highly interrelated and sometimes correlated. Consequently, when conducting Immatics's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Immatics
Click cells to compare fundamentals

Immatics Valuation Trend

Knowing Immatics' actual value is paramount for traders to make sound investment determinations. Immatics' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Immatics' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Immatics' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Immatics Market Cap

Immatics NV is rated second overall in market capitalization category among related companies. Market capitalization of Biotechnology industry is currently estimated at about 2.26 Billion. Immatics totals roughly 663.06 Million in market capitalization claiming about 29% of stocks in Biotechnology industry.
Capitalization  Total debt  Revenue  Workforce  Valuation

Immatics Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Immatics's current stock value. Our valuation model uses many indicators to compare Immatics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Immatics competition to find correlations between indicators driving Immatics's intrinsic value. More Info.
Immatics NV is currently regarded as number one stock in price to book category among related companies. It is rated fourth overall in price to sales category among related companies fabricating about  1.23  of Price to Sales per Price to Book. Price to Sales Ratio is likely to rise to 12.55 in 2022. Comparative valuation analysis is a catch-all model that can be used if you cannot value Immatics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Immatics' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Immatics' earnings, one of the primary drivers of an investment's value.

About Immatics Valuation

The equity valuation mechanism determines the current worth of Immatics NV on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Immatics NV. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Immatics NV based exclusively on its fundamental and basic technical indicators. By analyzing Immatics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Immatics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Immatics. We calculate exposure to Immatics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Immatics's related companies.
Last ReportedProjected for 2022
Gross Profit35.9 M29.2 M
Profit Margin(7.77) (8.38) 
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor based immunotherapies for the treatment of cancer in the United States. The company has a strategic collaboration agreement with GlaxoSmithKline plc to develop novel adoptive cell therapies targeting multiple cancer indications MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies Celgene Switzerland LLC to develop novel adoptive cell therapies targeting multiple cancers Genmab AS to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications Amgen Inc. and MorphoSys to develop novel antibody-based therapies against various cancer antigens that are recognized by T cells. Immatics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 331 people.

Immatics Quarterly Enterprise Value

637.78 MillionShare

Immatics Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Immatics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio1.65
Revenue Growth-18.10%
Enterprise Value To Ebitda-7.33
Enterprise Value To Revenue22.55

Immatics Current Valuation Indicators

Valuation refers to the process of determining the present value of Immatics NV and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Immatics we look at many different elements of the entity such as Immatics's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Immatics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Immatics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Immatics' worth.
Please see Risk vs Return Analysis. Note that the Immatics NV information on this page should be used as a complementary analysis to other Immatics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Immatics Stock analysis

When running Immatics NV price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Is Immatics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immatics. If investors know Immatics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immatics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immatics NV is measured differently than its book value, which is the value of Immatics that is recorded on the company's balance sheet. Investors also form their own opinion of Immatics' value that differs from its market value or its book value, called intrinsic value, which is Immatics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immatics' market value can be influenced by many factors that don't directly affect Immatics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immatics' value and its price as these two are different measures arrived at by different means. Investors typically determine Immatics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immatics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.